Anavex will beat the snot out of Neurotrope and that is what he is afraid of. Their drug is limited in scope, Anavex is doing testing in multiple CNS indications. Do your own DD....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.